Transmitter systems involved in neural plasticity underlying increased anxiety and defense implications for understanding anxiety following traumatic stress

Neuroscience and Biobehavioral Reviews

Volumn 21, Issue 6, 1997, Pages 755-765

  Adamec, R ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; N METHYL DEXTRO ASPARTIC ACID;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANXIETY; CAT; CONFERENCE PAPER; DEFENSIVE BEHAVIOR; KINDLING; LIMBIC SYSTEM; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; STRESS;

AGGRESSION; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; HUMANS; NEURONAL PLASTICITY; NEUROTRANSMITTER AGENTS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0030834465     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(96)00055-3     Document Type: Conference Paper

References (82)

1. Adamec, R. Normal and abnormal limbic system mechanisms of emotive biasing. In: Livingston, K. E. and Hornykiewicz, O. eds. Limbic Mechanisms. New York: Plenum Press; 1978: 405-455.
2. Adamec, R. Kindling, anxiety and limbic epilepsy: Human and animal perspectives. In: Wada, J. A. ed. Kindling 4. New York: Raven Press; 1990: 329-341.
3. Adamec, R. Does Kindling model anything clinically relevant? Biol. Psychiat. 27:249-279; 1990.
4. Adamec, R. E. Acute and lasting effects of FG-7142 on defensive and approach-attack behavior in cats - implications for models of anxiety which use response suppression. Journal of Psychopharmacology 5:29-55; 1991.
5. Adamec, R. E. Partial kindling of the ventral hippocampus: Identification of changes in limbic physiology which accompany changes in feline aggression and defense. Physiology and Behavior 49:443-453; 1991.
6. Adamec, R. Partial kindling of the ventral hippocampus: The role of the benzodiazepine receptor in changes in limbic physiology which accompany changes in feline defense. Physiology and Behavior 49 (3):443-453; 1993.
7. Adamec, R. E. Lasting effects of FG-7142 on anxiety, aggression and limbic physiology in the cat. Journal of Psychopharmacology 7:232-248; 1993.
8. Adamec, R. The anxiogenic effects of exposure of rats to natural threat (cats) in two strains of rat - effects on behavior in the elevated plus maze and acoustic startle - further support for a model of Post Traumatic Stress Disorder. Annual Meeting of the Behavioral Neuroscience Society, Clearwater Florida, May 19-24, 1994.
9. Adamec, R. Modelling anxiety disorders following chemical exposures. Toxicol. Industr. Hlth. 10 (4/5):391-420; 1994.
10. Adamec, R. Mechanisms of initiation and maintenance of increased generalized anxiety following traumatic stress. Society for Neuroscience, San Diego, California, November 11-16, 1995.
11. Adamec, R. E. Evidence that NMDA dependent limbic neural plasticity in the right hemisphere mediates stressor induced lasting increases in anxiety-like behavior - a model of limbic plasticity in Post-traumatic Stress Disorder? J. Psychopharmacol. in press.
12. Adamec, R. E. Antecedents of anxiety-like behavior produced by the stress of predator exposure - a path analytic study - implications for anxiety associated with Post-traumatic Stress Disorder. J. Psychopharmacol. submitted.
13. Adamec, R. E.; Shallow, T. Lasting effects on rodent anxiety of a single exposure to a cat. Physiology and Behavior 54:101-109; 1993.
14. Adamec, R. E.; Shallow, T.; Budgell, J. Pharmacological prophylaxis of anxiety in PTSD, suggestions from an animal model. Nature in press.
15. Adamec, R.; Stark-Adamec, C. Partial kindling and emotional bias in the cat: Lasting after-effects of partial kindling of ventral hippocampus. I: behavioral changes. Behav. Neur. Biol. 38:205-222; 1983.
16. Adamec, R.; Stark-Adamec, C. Partial kindling and emotional bias in the cat: Lasting after-effects of partial kindling of ventral hippocampus. II: physiological changes. Behav. Neur. Biol. 38:223-239; 1983.
17. Arora, P. K.; Hanna, E. E.; Skolnick, P. Suppression of cytotoxic T lymphocyte (CTL) activity by FG 7142, a benzodiazepine receptor 'inverse agonist'. Immunopharmacology 21:91-98; 1991.
18. Audi, E. A.; De Oliveira, R. M. W.; Graeff, F. G. Microinjection of propranolol into the dorsal periaqueductal gray causes an anxiolytic effect in the elevated plus-maze antagonized by ritanserin. Psychopharmacology 105:553-557; 1991.
19. Bandopadhyay, R.; De Belleroche, J. Regulation of CCK release in cerebral cortex by N-methyl-D-aspartate receptors: Sensitivity to APV, MK-801, kynurenate, magnesium and zinc ions. Neuropeptides 18:159-163; 1991.
20. Belzung, C.; Pineau, N.; Beuzen, A.; Misslin, R. PD135158, a CCK-B antagonist, reduces 'state' but not 'trait' anxiety in mice. Pharmacol. Biochem. Behav. 49:433-436; 1994.
21. 4-induced anxiety in normal healthy volunteers. Am. J. Psychiat. 152:1180-1184; 1995.
22. Bickerdike, M. J.; Marsden, C. A.; Dourish, C. T.; Fletcher, A. The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze. Eur. J. Pharmacol. 271:403-411; 1994.
23. Blanchard, R. J.; Blanchard, D. C. Antipredatory defensive behaviors in a visible burrow system. J. Comp. Psychol. 103:70-82; 1989.
24. Blanchard, R. J.; Blanchard, D. C.; Rodgers, J.; Weiss, S. M. The characterization and modelling of antipredator defensive behavior. Neurosci. Biobehav. Rev. 14:463-472; 1990.
25. Bradberry, C. W.; Lory, J. D.; Roth, R. H. The anxiogenic β-carboline FG 7142 selectively increases dopamine release in rat prefrontal cortex as measured by microdialysis. J. Neurochem. 56:748-752; 1991.
26. Bradwejn, J.; Koszycki, D. The cholecystokinin hypothesis of anxiety and panic disorder. Ann. N. Y. Acad. Sci. 713:273-282; 1994.
27. Butler, R. W.; Braff, D. L.; Rausch, J. L.; Jenkins, M. A.; Sprock, J.; Geyer, M. A. Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD. Am. J. Psychiat. 147:1308-1312; 1990.
28. Byrne, B. M. Structural equation modelling with EQS and EQS/Windows. London: Sage Publications; 1994.
29. Cabib, S.; Puglisi-Allegra, S. Opposite responses of mesolimbic dopamine system to controllable and uncontrollable aversive experiences. J. Neurosci. 14:3333-3340; 1994.
30. Cain, D. P. Long-term potentiation and kindling: how similar are the mechanisms? Trends Neurosci. 12:6-10; 1989.
31. Campeau, S.; Miserendino, M. J. D.; Davis, M. Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 blocks acquisition but not expression of fear-potentiated startle to an auditory conditioned stimulus. Behav. Neurosci. 106:569-574; 1992.
32. Cole, B. J.; Stephens, D. N.; Hillman, M.; Seidelmann, D.; Jones, G. H. Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in rats. Soc. Neurosci. Abstr. 19; 1993.
33. Coleman-Mesches, K.; McGaugh, J. L. Muscimol injected into the right or left amygdaloid complex differentially affects retention performance following aversively motivated training. Brain Res. 676:183-188; 1995.
34. Coleman-Mesches, K.; McGaugh, J. L. Differential effects of pretraining inactivation of the right or left amygdala on retention of inhibitory avoidance training. Behav. Neurosci. 109:642-647; 1995.
35. Collingridge, G. L.; Bliss, T. V. P. Memories of NMDA receptors and LTP. Trends Neurosci. 18:54-56; 1995.
36. Corda, M. G.; Giorgi, O.; Mele, S.; Biggio, G. Enhanced sensitivity to beta-carboline inverse agonists in rats chronically treated with FG 7142. Brain Res. Bull. [B5M] 19:379-380; 1987.
37. Davis, M.; Falls, W. A.; Campeau, S.; Kim, M. Fear-potentiated startle: A neural and pharmacological analysis. Behav. Brain Res. 58:175-198; 1993.
38. Dorrow, R.; Horowski, R.; Paschelke, F.; Amin, M.; Braestrup, C. Severe anxiety induced by FG-7142, a βcarboline ligand for benzodiazepine receptors. Lancet 2:98-99; 1983.
39. DSM III-R - Diagnositc and statistical manual of mental disorders, Version III (Revised). Washington, DC: American Psychiatric Association; 1987.
40. DSM IV - Diagnositc and statistical manual of mental disorders, Version 4. Washington, DC: American Psychiatric Association; 1994.
41. File, S. E.; Pellow, S. The anxiogenic action of FG-7142 in the social interaction test is reversed by chlordiazepoxide and RO-15-1788 but not by CGS 8216. Arch. Int. Pharmacodyn. 271:198-208; 1986.
42. File, S. E. The contribution of behavioural studies to the neuropharmacology of anxiety. Neuropharmacology 26:877-886; 1987.
43. File, S. E.; Johnston, A. L.; Baldwin, H. A. Anxiolytic and anxiogenic drugs: changes in behaviour and endocrine responses. Stress Med. 4:221-230; 1988.
44. File, S. E.; Zangrossi, H. Jr.; Sanders, F. L.; Mabbutt, P. S. Raised corticosterone in the rat after exposure to the elevated plus-maze. Psychopharmacology 113:543-546; 1994.
45. Graeff, F. G.; Silveira, M. C. L.; Nogueira, R. L.; Audi, E. A.; Oliveira, R. M. W. Role of the amygdala and periaqueductal gray in anxiety and panic. Behav. Brain Res. 58:123-131; 1993.
46. Griffin, N.; Engel, J.; Bandler, R. Ictal and enduring interictal disturbances in emotional behavior in an animal model of temporal lobe epilepsy. Brain Res. 400:360-364; 1987.
47. Guimaraes, F. S.; De Aguiar, J. C.; Del Bel, E. A.; Ballejo, G. Anxiolytic effect of nitric oxide synthase inhibitors microinjected into the dorsal central grey. NeuroReport 5:1929-1932; 1994.
48. Hesson, J. Relationships between anxiety, startle, aggression and guilt in Viet Nam veterans suffering from PTSD. Masters Thesis, Memorial University, Canada; 1996.
49. Hiyoshi, T.; Matsuda, M.; Wada, J. A. Centrally induced feline emotional behavior and limbic kindling. Epilepsia 31:259-269; 1990.
50. Lanaud, P.; Popovici, T.; Normand, E.; Lemoine, C.; Bloch, B.; Roques, B. P. Distribution of CCK mRNA in particular regions (hippocampus, periaqueductal grey and thalamus) of the rat by in situ hybridization. Neurosci. Lett. 104:38-42; 1989.
51. Liu, H.; Chandler, S.; Beitz, A. J.; Shipley, M. T.; Behbehani, M. M. Characterization of the effect of cholecystokinin (CCK) on neurons in the periaqueductal gray of the rat: Immunocytochemical and in vivo and in vitro electrophysiological studies. Brain Res. 642:83-94; 1994.
52. Lu, C.-L.; Shaikh, M. B.; Siegel, A. Role of NMDA receptors in hypothalamic facilitation of feline defensive rage elicited from the midbrain periaqueductal gray. Brain Res. 581:123-132; 1992.
53. Malenka, R. C.; Nicoll, R. A.; Nicoll, R. A. NMDA-receptor-dependent synaptic plasticity: Multiple forms and mechanisms. Trends Neurosci. 16:521-527; 1993.
54. Mindy, J. D.; Miserendino, M. J. D.; Sananes, C. B.; Melia, K. R.; Davis, M. Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature 345:716-718; 1990.
55. Miserendino, M. J. D.; Davis, M. NMDA and non-NMDA antagonists infused into the nucleus reticularis pontis caudalis depress the acoustic startle reflex. Brain Res. 623:215-222; 1993.
56. Morgan III, C. A.; Grillon, C.; Southwick, S. M.; Davis, M.; Charney, D. S. Fear-potentiated startle in posttraumatic stress disorder. Biol. Psychiat. 38:378-385; 1995.
57. Mosnaim, A. D.; Wolf, M. E.; Maturana, P.; Mosnaim, G.; Puente, J.; Kucuk, O.; Gilman-Sachs, A. In vitro studies of natural killer cell activity in post traumatic stress disorder patients. Response to methionine-enkephalin challenge. Immunopharmacology 25:107-116; 1993.
58. Motta, V.; Brandao, M. L. Aversive and antiaversive effects of morphine in the dorsal periaqueductal gray of rats submitted to the elevated plus-maze test. Pharmacol. Biochem. Behav. 44:119-125; 1993.
59. Nashold, B. S. Jr.; Wilson, N. P.; Slaughter, G. S. Sensations evoked by stimulation in the midbrain of man. J. Neurosurg. 30:14-24; 1969.
60. Nashold, B. S. Jr; Wilson, N.P.; Slaughter, G. S. The midbrain and pain. In: Bonica, J. J. ed. Advances in neurology, vol. 4 international symposium on pain. New York: Raven Press; 1974:191-196.
61. Nutt, D. Pharmacological approaches to human anxiety. Brain Research Association 12th Annual Meeting, Oxford, March, 1995.
62. Nutt, D. J.; Glue, P.; Lawson, C.; Wilson, S. Flumazenil provocation of panic attacks: Evidence for altered benzodiazepine receptor sensitivity in panic disorder. Archs Gen. Psychiat. 47:917-925; 1990.
63. Ornitz, E. M.; Pynoos, R. S. Startle modulation in children with post traumatic stress disorder. Am. J. Psychiat. 146:866-870; 1989.
64. Pitman, R.; Orr, S. P. Twenty-four hour urinary cortisol, catecholamine excretion in combat-related posttraumatic stress disorder. Biol. Psychiat. 27:245-247; 1990.
65. Rauch, S. L.; Van der Kolk, B.; Fisler, R. E.; Alpert, N. M.; Orr, S. P.; Savage, C. R.; Fischman, A. J.; Jenike, M. A.; Pitman, R. K. A symptom provocation study of posttraumatic stress disorder using positron emission tomography, script-driven imagery. Archs Gen. Psychiat. 53: 380-87; 1996.
66. Ross, R. J.; Ball, W. A.; Cohen, M. E. Habituation of the startle response in post traumatic stress disorder. J. Neuropsychiat. 1:305-307; 1989.
67. Russo, A. S.; Guimaraes, F. S.; De Aguiar, J. C.; Graeff, F. G. Role of benzodiazepine receptors located in the dorsal periaqueductal grey of rats in anxiety. Psychopharmacology 110:198-202; 1993.
68. Sackeim, H. A. Emotion, disorders of mood, hemispheric functional specialization. In: Carroll, B. J.; Barrett, J. E. eds. Pschopathology; the brain. New York: Raven Press; 1991:209-242.
69. Shaikh, M. B.; Lu, C.-L.; Siegel, A. An enkephalinergic mechanism involved in amygdaloid suppression of affective defence behavior elicited from the midbrain periaqueductal gray in the cat. Brain Res. 559:109-117; 1991.
70. Shaikh, M. B.; Schubert, K.; Siegel, A. Basal amygdaloid facilitation of midbrain periaqueductal gray elicited defensive rage behavior in the cat is mediated through NMDA receptors. Brain Res. 635:187-195; 1994.
71. Shalev, A. Y.; Orr, S. P.; Peri, T.; Schreiber, S.; Pitman, R. K. Physiological responses to loud tones in Israeli patients with post traumatic stress disorder. Arch. Gen. Psychiat. 49:870-875; 1993.
72. Short, K. R.; Maier, S. F. Stressor controllability, social interaction; benzodiazepine systems. Pharmacol. Biochem. Behav. 45:827-835; 1993.
73. Siegel, A. Anatomical, functional differentiation within the amygdala - behavioral state modulation. In: Bandler, R., ed. Modulation of sensorimotor activity during altered behavioral states. New York: Alan R. Liss; 1984:299-324.
74. Silveira, M. C. L.; Siner, G.; Graeff, F. G. Induction of Fos immunoreactivity in the brain by exposure to the elevated plus-maze. Behav. Brain Res. 56:115-118; 1993.
75. Skolnick, P.; Paul, S. M. New concepts in the neurobiology of anxiety. J. Clin. Psychiatr. 44:12-19; 1983.
76. Speed, N.; Engdahl, B.; Schwartz, J.; Eberly, R. Posttraumatic stress disorder as a consequence of the POW experience. J. Nerv. Nemt. Dis. 177 (3):273-289; 1989.
77. Van der Kolk, B. A. The body keeps the score: memory; the evolving psychobiology of posttraumatic stress disorder. Harvard Rev. Psychiatry, Jan/Feb:253-265; 1994.
78. B-receptor activation augments the long-term potentiation in guinea pig hippocampal slices. Jpn. J. Pharmacol. 68:441-447; 1995.
79. Yehuda, R.; Resnick, H.; Kahana, B.; Giller, E. L. Long-lasting hormonal alterations to extreme stress in humans: normative or maladaptive. Psychosom. Med. 55:287-297; 1993.
80. Adamec, R. E.; McKay, D. Amygdala kindling, anxiety, and corticotrophin releasing factor (CRF). Physiol. Behav. 53:423-431; 1993.
81. Lasko, N. B.; Gurvits, T. V.; Kuhne, A.A.; Orr, S. P.; Pitman, R. K. Aggression and its correlates in Vietnam veterans with and without chronic post traumatic stress disorder. Comprehen. Psychiatr. 35:373-381; 1994.
82. Lee, Y. S.-Y.; Poon, W.-Y.; Bentler, P. M. A three-stage estimation procedure for structural equation models with polytomous variables. Psychometrika 55:45-51; 1990.